Skip to content
★ Sign in to follow
JOINN Laboratories (China) Co., Ltd. logo

JOINN Laboratories (China) Co., Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$17.7BHealth Care

No insider purchase over the last 90 days. The latest, by Gu Jingliang, was filed 07 May 2026.

JOINN Laboratories (China) Co., Ltd.: what insiders have been doing

JOINN Laboratories (China) Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to HKEX. 6 insiders have disclosed 6 filings since 22 October 2025.

No insider sold shares on the market over the period. Instead, the filings list 6 purchases, made by 6 insiders. No amount is published for 6 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 6 senior executives.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 6 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 6 purchases and no sales.

The clock since the last published purchase (7 May 2026) now reads 186 days. Between a trade and the moment it shows up on HKEX, the median delay is 7 days. The shorter that gap, the sooner other investors can see what insiders have done.

For comparison within the same sector, see the insider buying recorded at UCB. This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
6 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Feng Yuxia1 buy
Gao Dapeng1 buy
Gu Jingliang1 buy
Li Ye1 buy
Luo Xi1 buy
Sun Yunxia1 buy

Since the insiders bought

  • Filed 07 May 2026 · 186 days ago
    +30.0%
    Entry HK$20.50 · Close 21 Oct 2026 HK$26.66
  • Filed 07 May 2026 · 186 days ago
    +30.0%
    Entry HK$20.50 · Close 21 Oct 2026 HK$26.66
  • Filed 07 May 2026 · 186 days ago
    +30.0%
    Entry HK$20.50 · Close 21 Oct 2026 HK$26.66

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Analyst consensus: bullish or bearish?

Analysts rate JOINN Laboratories (China) Co., Ltd. Buy (bullish), based on 5 analysts. Average price target: HK$24.99.

Fundamental score
Ranked 13,840 of 26,913 companies
50.7
score / 100
Value
32
Quality
69
FCF yld1.7%
Earn yld1.7%
EV/EBITDA36.6x
ROE12%
Gross mgn21%
Net mgn18%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$27.44
Analyst consensus
5 analysts
Buy
HK$7.04Target HK$24.99(-9%)HK$37.81
Income statement
RevenueHK$1.7B
Gross profitHK$343.3M21% margin
EBITDAHK$483.2M29% margin
Net incomeHK$297.8M58.2% margin
Valuation
PER (trailing)18.7x
PER (forward)94.7x
P/Book2.0x
Beta0.87
Balance sheet & cash
Market capHK$17.7B
Total debtHK$21.6M
Free Cash FlowHK$301M
Debt / Equity0%
Profitability & ownership
ROE11.5%
ROA-0.7%
% insiders15.9%
% institutions25.8%
Last declaration on 7 May 2026
Declarations6 total
  • ▲
    DirectorExecutives
    0HKEX
    80,000 sharesShareXHKGHKEX:DA20260506E00397
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    500,000 sharesShareXHKGHKEX:DA20260506E00389
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    30,000 sharesShareXHKGHKEX:DA20260506E00412
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    60,000 sharesShareXHKGHKEX:DA20260506E00421
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    60,000 sharesShareXHKGHKEX:DA20260506E00402
    Canonical exit: 29 Jul 2026 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    60,000 sharesShareXHKGHKEX:DA20260506E00430
    Canonical exit: 29 Jul 2026 (T+90)

6 of 6 declarations

About JOINN Laboratories (China) Co., Ltd.

JOINN Laboratories (China) Co., Ltd. is a company focused on drug research and development, as well as preclinical and clinical testing services. It is listed on the Hong Kong Stock Exchange.